Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Finmo today announced the appointment of Josh D'Ambrosio as Chief Commercial Officer (CCO), responsible for establishing and scaling Finmo's global go-to-market engine, driving commercial growth and ...
MakeMyTrip group CEO Rajesh Magow said the optimism level among airlines is improving, and noted that commercial LPG supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results